Development of the market environment for generics and biosimilars through policy measures

Against the backdrop of the government’s targets for promoting the use of generic drugs and biosimilars, the healthcare reimbursement system, and promotional activities by councils and industry associations, this theme anticipates growing demand for both product groups and the formation of their markets.